Top 17 Kiniksa Pharmaceuticals investors
The most complete profiles first. Showing 17 of 17.
Adam GreeneVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Jonathan LeffVerified
Venture Capital, Investor · United States
SeedSeries BHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more
Verified email available
Narendra NayakVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Nicholas BishopVerified
Hedge Fund, Venture Capital, Investment Partner · United States
Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information ServicesPortfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Sarah BhagatVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Alan ColowickVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Howie FurstVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Jason PittsVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Kevin BergVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Contact details available
Mike PowellVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Vincent MelletVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
James Flynn
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information ServicesPortfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 80 more
Contact details available
Maha Katabi, PhD, CFA
Hedge Fund, Venture Capital, Investor · Canada
SeedHealth CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more
Contact details available
Perry Nisen
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Alfred Yue
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Avi Kometz
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Contact details available
Hooman Shahlavi
Hedge Fund, Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Kiniksa Pharmaceuticals investors are on Angel Roster?
Angel Roster lists 17 Kiniksa Pharmaceuticals investors. 10 of them (59%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (13), Hedge Funds (10) and Investment Partner Investors (5). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Kiniksa Pharmaceuticals investors invest in?
Among those that list a stage, the most common are Series B (5) and Seed (4).
Where are Kiniksa Pharmaceuticals investors based?
Most are based in the United States (16) and Canada (1).
Which companies have Kiniksa Pharmaceuticals investors backed?
The most-backed portfolio companies among them are Spark Therapeutics (17), Audentes Therapeutics (17), VelosBio (9), Histogenics (9) and Civitas Therapeutics (9).
How do I contact Kiniksa Pharmaceuticals investors?
Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.